Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 8 | 2026 | 324 | 2.920 |
Why?
|
| Psychotic Disorders | 5 | 2022 | 146 | 1.830 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2025 | 3436 | 1.070 |
Why?
|
| Neuroimmunomodulation | 1 | 2025 | 18 | 0.920 |
Why?
|
| Genes, Recessive | 1 | 2025 | 193 | 0.830 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 629 | 0.670 |
Why?
|
| Dementia | 1 | 2026 | 436 | 0.670 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 1833 | 0.650 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2019 | 6 | 0.590 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 338 | 0.530 |
Why?
|
| Schizophrenic Psychology | 2 | 2014 | 81 | 0.500 |
Why?
|
| Suicide, Attempted | 2 | 2014 | 150 | 0.460 |
Why?
|
| Pharmacogenetics | 2 | 2026 | 201 | 0.410 |
Why?
|
| Neural Stem Cells | 2 | 2025 | 133 | 0.350 |
Why?
|
| Suicidal Ideation | 1 | 2014 | 254 | 0.340 |
Why?
|
| Obsessive-Compulsive Disorder | 3 | 2026 | 897 | 0.320 |
Why?
|
| Cognition Disorders | 1 | 2014 | 556 | 0.310 |
Why?
|
| Inpatients | 1 | 2014 | 562 | 0.310 |
Why?
|
| Cognition | 1 | 2014 | 829 | 0.280 |
Why?
|
| Autism Spectrum Disorder | 2 | 2025 | 450 | 0.270 |
Why?
|
| Lewy Body Disease | 1 | 2026 | 15 | 0.240 |
Why?
|
| Polypharmacy | 1 | 2026 | 36 | 0.240 |
Why?
|
| Humans | 24 | 2026 | 131163 | 0.230 |
Why?
|
| Severity of Illness Index | 2 | 2026 | 3061 | 0.230 |
Why?
|
| Psychotropic Drugs | 1 | 2026 | 123 | 0.220 |
Why?
|
| Case-Control Studies | 5 | 2025 | 3359 | 0.220 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2025 | 50 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2024 | 33 | 0.210 |
Why?
|
| Loss of Function Mutation | 2 | 2021 | 177 | 0.200 |
Why?
|
| Rare Diseases | 1 | 2025 | 210 | 0.190 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 373 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 56 | 0.180 |
Why?
|
| Psychiatry | 1 | 2025 | 272 | 0.180 |
Why?
|
| Mental Disorders | 3 | 2025 | 910 | 0.180 |
Why?
|
| Temporal Lobe | 1 | 2022 | 110 | 0.180 |
Why?
|
| Middle Aged | 7 | 2026 | 28601 | 0.170 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 100 | 0.170 |
Why?
|
| Machine Learning | 1 | 2025 | 387 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2021 | 919 | 0.160 |
Why?
|
| Computational Biology | 1 | 2025 | 862 | 0.160 |
Why?
|
| Risk | 1 | 2021 | 726 | 0.150 |
Why?
|
| Male | 10 | 2026 | 64957 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2025 | 1345 | 0.150 |
Why?
|
| Alleles | 1 | 2024 | 1673 | 0.150 |
Why?
|
| Biomarkers | 2 | 2025 | 3385 | 0.150 |
Why?
|
| Aged | 4 | 2026 | 21025 | 0.140 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1029 | 0.140 |
Why?
|
| Interview, Psychological | 1 | 2019 | 101 | 0.140 |
Why?
|
| Antipsychotic Agents | 2 | 2020 | 375 | 0.140 |
Why?
|
| Female | 9 | 2026 | 70963 | 0.140 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 134 | 0.130 |
Why?
|
| Hypertension | 1 | 2025 | 1356 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1419 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 781 | 0.120 |
Why?
|
| Syndrome | 1 | 2019 | 1155 | 0.120 |
Why?
|
| Research Personnel | 1 | 2017 | 139 | 0.120 |
Why?
|
| Genomics | 1 | 2023 | 1621 | 0.110 |
Why?
|
| Pharmacogenomic Testing | 2 | 2026 | 47 | 0.110 |
Why?
|
| Risk Factors | 3 | 2025 | 11074 | 0.110 |
Why?
|
| Heroin | 1 | 2014 | 19 | 0.100 |
Why?
|
| Phenotype | 1 | 2024 | 4497 | 0.100 |
Why?
|
| Heroin Dependence | 1 | 2014 | 57 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1103 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 89 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2026 | 17753 | 0.100 |
Why?
|
| Adult | 6 | 2026 | 31282 | 0.100 |
Why?
|
| Attention | 1 | 2014 | 194 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2323 | 0.090 |
Why?
|
| Language | 1 | 2014 | 219 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1459 | 0.090 |
Why?
|
| Memory | 1 | 2014 | 314 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3829 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 960 | 0.080 |
Why?
|
| Neurons | 1 | 2020 | 1979 | 0.080 |
Why?
|
| Brain | 1 | 2022 | 3175 | 0.080 |
Why?
|
| Animals | 4 | 2025 | 33912 | 0.080 |
Why?
|
| Mutation | 1 | 2023 | 6099 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 350 | 0.080 |
Why?
|
| Young Adult | 2 | 2026 | 10103 | 0.070 |
Why?
|
| Adolescent | 3 | 2026 | 20987 | 0.070 |
Why?
|
| Receptors, Eph Family | 1 | 2008 | 20 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 138 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 106 | 0.060 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2025 | 37 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2025 | 55 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2025 | 94 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2024 | 26 | 0.050 |
Why?
|
| Delayed Diagnosis | 1 | 2025 | 131 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2025 | 206 | 0.050 |
Why?
|
| Latin America | 1 | 2023 | 110 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2025 | 297 | 0.050 |
Why?
|
| Haplotypes | 1 | 2024 | 519 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 718 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 38 | 0.050 |
Why?
|
| Epirizole | 1 | 2020 | 2 | 0.040 |
Why?
|
| Trimipramine | 1 | 2020 | 2 | 0.040 |
Why?
|
| Perphenazine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Trazodone | 1 | 2020 | 6 | 0.040 |
Why?
|
| Carbamazepine | 1 | 2020 | 40 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 45 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 106 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1590 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 176 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 209 | 0.040 |
Why?
|
| Risperidone | 1 | 2020 | 59 | 0.040 |
Why?
|
| Hippocampus | 1 | 2025 | 806 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1882 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 112 | 0.040 |
Why?
|
| Age Factors | 1 | 2026 | 2825 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 362 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 179 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 889 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 292 | 0.040 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2018 | 20 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 238 | 0.030 |
Why?
|
| Genotype | 1 | 2024 | 2595 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2020 | 363 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 321 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2020 | 674 | 0.030 |
Why?
|
| Quality of Life | 1 | 2026 | 2082 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 18301 | 0.030 |
Why?
|
| Child | 2 | 2026 | 26341 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1129 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2014 | 150 | 0.020 |
Why?
|
| China | 1 | 2013 | 278 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 237 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 563 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5063 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6459 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2426 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2013 | 218 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 830 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 15110 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1246 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2008 | 173 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 214 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 291 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 208 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 481 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 716 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 251 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2008 | 161 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2701 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2552 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 4066 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 789 | 0.010 |
Why?
|